
The global AI-enabled Diagnostic Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI-enabled Diagnostic Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-enabled Diagnostic Imaging.
Report Scope
The AI-enabled Diagnostic Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-enabled Diagnostic Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-enabled Diagnostic Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthineers
Nuance Communication
Koninklijke Philips
Arterys
Samsung Electronics
Zebra Medical Vision
Bay Labs
IBM Corporation
NVIDIA
Alibaba Cloud
Neusoft
Segment by Type
Software
Service
Segment by Application
Hospitals
R&D centers
Laboratories and Diagnostic centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-enabled Diagnostic Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-enabled Diagnostic Imaging Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Service
1.3 Market by Application
1.3.1 Global AI-enabled Diagnostic Imaging Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 R&D centers
1.3.4 Laboratories and Diagnostic centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-enabled Diagnostic Imaging Market Perspective (2019-2030)
2.2 AI-enabled Diagnostic Imaging Growth Trends by Region
2.2.1 Global AI-enabled Diagnostic Imaging Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-enabled Diagnostic Imaging Historic Market Size by Region (2019-2024)
2.2.3 AI-enabled Diagnostic Imaging Forecasted Market Size by Region (2025-2030)
2.3 AI-enabled Diagnostic Imaging Market Dynamics
2.3.1 AI-enabled Diagnostic Imaging Industry Trends
2.3.2 AI-enabled Diagnostic Imaging Market Drivers
2.3.3 AI-enabled Diagnostic Imaging Market Challenges
2.3.4 AI-enabled Diagnostic Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-enabled Diagnostic Imaging Players by Revenue
3.1.1 Global Top AI-enabled Diagnostic Imaging Players by Revenue (2019-2024)
3.1.2 Global AI-enabled Diagnostic Imaging Revenue Market Share by Players (2019-2024)
3.2 Global AI-enabled Diagnostic Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI-enabled Diagnostic Imaging Revenue
3.4 Global AI-enabled Diagnostic Imaging Market Concentration Ratio
3.4.1 Global AI-enabled Diagnostic Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-enabled Diagnostic Imaging Revenue in 2023
3.5 AI-enabled Diagnostic Imaging Key Players Head office and Area Served
3.6 Key Players AI-enabled Diagnostic Imaging Product Solution and Service
3.7 Date of Enter into AI-enabled Diagnostic Imaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-enabled Diagnostic Imaging Breakdown Data by Type
4.1 Global AI-enabled Diagnostic Imaging Historic Market Size by Type (2019-2024)
4.2 Global AI-enabled Diagnostic Imaging Forecasted Market Size by Type (2025-2030)
5 AI-enabled Diagnostic Imaging Breakdown Data by Application
5.1 Global AI-enabled Diagnostic Imaging Historic Market Size by Application (2019-2024)
5.2 Global AI-enabled Diagnostic Imaging Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI-enabled Diagnostic Imaging Market Size (2019-2030)
6.2 North America AI-enabled Diagnostic Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-enabled Diagnostic Imaging Market Size by Country (2019-2024)
6.4 North America AI-enabled Diagnostic Imaging Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-enabled Diagnostic Imaging Market Size (2019-2030)
7.2 Europe AI-enabled Diagnostic Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-enabled Diagnostic Imaging Market Size by Country (2019-2024)
7.4 Europe AI-enabled Diagnostic Imaging Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-enabled Diagnostic Imaging Market Size (2019-2030)
8.2 Asia-Pacific AI-enabled Diagnostic Imaging Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-enabled Diagnostic Imaging Market Size by Region (2019-2024)
8.4 Asia-Pacific AI-enabled Diagnostic Imaging Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-enabled Diagnostic Imaging Market Size (2019-2030)
9.2 Latin America AI-enabled Diagnostic Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-enabled Diagnostic Imaging Market Size by Country (2019-2024)
9.4 Latin America AI-enabled Diagnostic Imaging Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-enabled Diagnostic Imaging Market Size (2019-2030)
10.2 Middle East & Africa AI-enabled Diagnostic Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-enabled Diagnostic Imaging Market Size by Country (2019-2024)
10.4 Middle East & Africa AI-enabled Diagnostic Imaging Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthineers
11.1.1 Siemens Healthineers Company Detail
11.1.2 Siemens Healthineers Business Overview
11.1.3 Siemens Healthineers AI-enabled Diagnostic Imaging Introduction
11.1.4 Siemens Healthineers Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.1.5 Siemens Healthineers Recent Development
11.2 Nuance Communication
11.2.1 Nuance Communication Company Detail
11.2.2 Nuance Communication Business Overview
11.2.3 Nuance Communication AI-enabled Diagnostic Imaging Introduction
11.2.4 Nuance Communication Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.2.5 Nuance Communication Recent Development
11.3 Koninklijke Philips
11.3.1 Koninklijke Philips Company Detail
11.3.2 Koninklijke Philips Business Overview
11.3.3 Koninklijke Philips AI-enabled Diagnostic Imaging Introduction
11.3.4 Koninklijke Philips Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.3.5 Koninklijke Philips Recent Development
11.4 Arterys
11.4.1 Arterys Company Detail
11.4.2 Arterys Business Overview
11.4.3 Arterys AI-enabled Diagnostic Imaging Introduction
11.4.4 Arterys Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.4.5 Arterys Recent Development
11.5 Samsung Electronics
11.5.1 Samsung Electronics Company Detail
11.5.2 Samsung Electronics Business Overview
11.5.3 Samsung Electronics AI-enabled Diagnostic Imaging Introduction
11.5.4 Samsung Electronics Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.5.5 Samsung Electronics Recent Development
11.6 Zebra Medical Vision
11.6.1 Zebra Medical Vision Company Detail
11.6.2 Zebra Medical Vision Business Overview
11.6.3 Zebra Medical Vision AI-enabled Diagnostic Imaging Introduction
11.6.4 Zebra Medical Vision Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.6.5 Zebra Medical Vision Recent Development
11.7 Bay Labs
11.7.1 Bay Labs Company Detail
11.7.2 Bay Labs Business Overview
11.7.3 Bay Labs AI-enabled Diagnostic Imaging Introduction
11.7.4 Bay Labs Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.7.5 Bay Labs Recent Development
11.8 IBM Corporation
11.8.1 IBM Corporation Company Detail
11.8.2 IBM Corporation Business Overview
11.8.3 IBM Corporation AI-enabled Diagnostic Imaging Introduction
11.8.4 IBM Corporation Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.8.5 IBM Corporation Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Detail
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA AI-enabled Diagnostic Imaging Introduction
11.9.4 NVIDIA Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.9.5 NVIDIA Recent Development
11.10 Alibaba Cloud
11.10.1 Alibaba Cloud Company Detail
11.10.2 Alibaba Cloud Business Overview
11.10.3 Alibaba Cloud AI-enabled Diagnostic Imaging Introduction
11.10.4 Alibaba Cloud Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.10.5 Alibaba Cloud Recent Development
11.11 Neusoft
11.11.1 Neusoft Company Detail
11.11.2 Neusoft Business Overview
11.11.3 Neusoft AI-enabled Diagnostic Imaging Introduction
11.11.4 Neusoft Revenue in AI-enabled Diagnostic Imaging Business (2019-2024)
11.11.5 Neusoft Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Siemens Healthineers
Nuance Communication
Koninklijke Philips
Arterys
Samsung Electronics
Zebra Medical Vision
Bay Labs
IBM Corporation
NVIDIA
Alibaba Cloud
Neusoft
Ìý
Ìý
*If Applicable.
